Helius Medical Technologies, Inc. Announces Study Results Demonstrating That PoNS Therapy™ Helps Patients with Traumatic Brain Injury A Collaborative Project with Pacific Blue Cross and HealthTech Connex Reducing Disability and Improving Quality of Life for TBI Sufferers Recently, Helius Medical Technologies, Inc. released groundbreaking study results showcasing the effectiveness of PoNS Therapy™ in helping individuals…

Offshore Mooring Systems Market to Reach US$ 2.5 Billion by 2030 The global offshore mooring systems market is expected to reach US$ 2.5 billion by 2030, with an annual growth rate of more than 3.4% says RationalStat Wilmington, Delaware, Nov. 06, 2023 (GLOBE NEWSWIRE) — According to RationalStat’s recent market study, the Global Offshore Mooring…

Attention Investors: Class Action Against Outlook Therapeutics, Inc. What You Need to Know Date of Announcement: November 5, 2023 Hey there, fellow investors! Have you heard the news about the recent class action lawsuit filed against Outlook Therapeutics, Inc. and certain officers? If not, let me catch you up to speed. According to Pomerantz LLP,…

Heading 1 Heading 2 Heading 3 The first experimental agent from the enLIGHTEN™ Discovery Platform is Alpha-201-macro1, an investigational viral immunotherapy designed to activate innate immune surveillance. This groundbreaking development in the field of medicine has the potential to revolutionize the way we approach treatment for various diseases. By harnessing the power of the immune…

Coinbase Posts Mixed Q3 Results Introduction Coinbase Global (Nasdaq: COIN) has managed to beat the market estimates with its third-quarter revenue of $674.1 million and an adjusted loss of $0.01 per share. However, shares of the crypto exchange plummeted nearly 5 percent due to the missed total trading volume expectations. Mixed Q3 Results of Coinbase…